首页/数据集/Table S1 from CD25high Effector Regulatory T Cells Hamper Responses to PD-1 Blockade in Triple-Negative Breast Cancer

Table S1 from CD25high Effector Regulatory T Cells Hamper Responses to PD-1 Blockade in Triple-Negative Breast Cancer

Figshare2023-09-15 更新2026-04-28 收录

三阴性乳腺癌治疗

PD-1阻断疗效评估

数据链接：

https://figshare.com/articles/dataset/Table_S1_from_CD25_sup_high_sup_Effector_Regulatory_T_Cells_Hamper_Responses_to_PD-1_Blockade_in_Triple-Negative_Breast_Cancer/30700984 数据链接链接失效反馈

官方服务：

资源简介：

Clinical characteristics of patients with breast cancer

应用场景：

创建时间：

2023-09-15

三阴性乳腺癌治疗

药物靶点发现

Resveratrol (RSV) is known to possess anticancer properties in many types of cancers like breast cancer, in which POLD1 may serve as a potential target. However, the anticancer mechanism of RSV on tri

NIAID Data Ecosystem70

Cytochalasin D as a potential MAPK family inhibitor for treating triple-negative breast cancer

三阴性乳腺癌治疗

MAPK信号通路

Cytochalasin D, a potent fungal metabolite, has garnered considerable attention due to its diverse biological activities and potential pharmacological applications. Renowned for its ability to disrupt

Taylor & Francis Group2025-02-27 更新50

Small molecule-mediated ERO1A inhibition in restraining aggressive breast cancer

三阴性乳腺癌治疗

ERO1A抑制剂药物研发

Cancer cells adapt to harsh environmental conditions by inducing the Unfolded Protein Response (UPR), of which ERO1A is one of the mediators. ERO1A aids protein folding by acting as a protein disulfid

NIAID Data Ecosystem40

Metadata record for the manuscript: Nivolumab in combination with cabozantinib for metastatic triple-negative breast cancer: A phase II and biomarker study

三阴性乳腺癌治疗

癌症免疫生物标志物

Summary This metadata record provides details of the data supporting the claims of the related manuscript: “Nivolumab in combination with cabozantinib for metastatic triple-negative breast cancer:

NIAID Data Ecosystem60

A novel orally available seleno-purine molecule suppresses triple-negative breast cancer cell proliferation and progression to metastasis by inducing cytostatic autophagy

三阴性乳腺癌治疗

自噬调控

Patients with triple-negative breast cancer (TNBC) often have a poor prognosis largely due to lack of effective targeted therapy. Using a library of seleno-purines coupled to a high-throughput biochem

NIAID Data Ecosystem50

Table S1 from CD25high Effector Regulatory T Cells Hamper Responses to PD-1 Blockade in Triple-Negative Breast Cancer

资源简介：

相关数据集